Search

Sharon N Bisaha

from Lambertville, NJ
Age ~77
Get Report
Also known as:
Sharon Nash Bisaha, Sharon M Bisaha, Sharon A Bisaha
Phone and address:
38 Buttonwood St, West Amwell, NJ 08530
(609) 397-2717
Related to:
John Michael Bisaha, 82
Connected to:
Kelly K Bisaha, 51Doriza M Bisaillon, 60Emile R Bisaillon, 71Jacques A Bisaillon, 53Joel Bisaillon, 69Yasmir K Bisal, 59Jeanette Bisamunyu, 65Renee Bisanti, 42Jyoti Bisarya, 56Mamta Bisarya, 63

Sharon Bisaha Phones & Addresses

  • 38 Buttonwood St, Lambertville, NJ 08530 (609) 397-2717
  • 180 N Union St, Lambertville, NJ 08530 (609) 397-2717
  • 118 S 21St St APT 503, Philadelphia, PA 19103 (908) 500-1840
  • 11 Forrest Blend Dr, Titusville, NJ 08560
  • Lawton, MI
  • 118 S 21St St APT 503, Philadelphia, PA 19103 (609) 709-3387

Work

Position: Food Preparation and Serving Related Occupations

Emails

s***[email protected]

Publications

Us Patents

Substituted Pyrazinone Melanin Concentrating Hormone Receptor-1 Antagonists And Methods

View page
US Patent:
8012984, Sep 6, 2011
Filed:
Sep 14, 2010
Appl. No.:
12/881234
Inventors:
Philip D. Stein - Pennington NJ, US
Sharon N. Bisaha - Lambertville NJ, US
Saleem Ahmad - Wall NJ, US
Khehyong Ngu - Pennington NJ, US
William N. Washburn - Titusville NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4965
US Classification:
51425506, 544405, 5462681, 548179, 5483061, 549471
Abstract:
The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula IAdditionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.

Substituted Pyrazinone Melanin Concentrating Hormone Receptor-1 Antagonists And Methods

View page
US Patent:
8067420, Nov 29, 2011
Filed:
Feb 16, 2011
Appl. No.:
13/028570
Inventors:
Philip D. Stein - Pennington NJ, US
Sharon N. Bisaha - Lambertville NJ, US
Saleem Ahmad - Wall NJ, US
Khehyong Ngu - Pennington NJ, US
William N. Washburn - Titusville NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/4965
US Classification:
51425506, 544405
Abstract:
The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula IAdditionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.

Hmg-Coa Reductase Inhibitors And Method

View page
US Patent:
20050171140, Aug 4, 2005
Filed:
Nov 15, 2004
Appl. No.:
10/989138
Inventors:
Stephen O'Connor - Lambertville NJ, US
Jeffrey Robl - Newtown PA, US
Saleem Ahmad - Wall NJ, US
Sharon Bisaha - Lambertville NJ, US
Natesan Murugesan - Princeton Juction NJ, US
Khehyong Ngu - Pennington NJ, US
Yan Shi - Flourtown PA, US
Philip Stein - Pennington NJ, US
Nachimuthu Soundararajan - Kendall Park NJ, US
Kenneth Natalie - Flemington NJ, US
Laxma Kolla - Plainsboro NJ, US
Justin Sausker - Middletown CT, US
Sandra Quinlan - West Simsbury CT, US
Junying Fan - Monmouth Junction NJ, US
Dejah Petsch - Ashford CT, US
Zhenrong Guo - East Brunswick NJ, US
International Classification:
A61K031/4745
C07D471/02
US Classification:
514300000, 546122000
Abstract:
Compounds are provided having the following structure and pharmaceutically acceptable salts thereof, wherein R, R, R, R, U, V, W, Y, and n are as defined above, which compounds are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and treating hyperlipidemia, dyslipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis as well as Alzheimer's disease and osteoporosis and may be employed as hormone replacement therapy. A method for treating the above diseases employing the above compounds is also provided.

Non-Basic Melanin Concentrating Hormone Receptor-1 Antagonists And Methods

View page
US Patent:
20090011994, Jan 8, 2009
Filed:
Jun 18, 2008
Appl. No.:
12/141228
Inventors:
Philip D. Stein - Pennington NJ, US
Sharon N. Bisaha - Lambertville NJ, US
Saleen Ahmad - Wall NJ, US
Khehyong Ngu - Pennington NJ, US
William N. Washburn - Titusville NJ, US
International Classification:
A61K 38/22
A61K 31/4965
C07D 241/18
A61K 31/497
A61P 3/04
A61P 3/10
A61K 31/60
C07D 401/04
A61K 31/675
US Classification:
514 12, 544385, 51425502, 51425312, 544359, 514 85, 514161
Abstract:
The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula IwhereinR, R, R, R, and Rare defined herein.Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I.

Antibacterial Quinolone Compounds

View page
US Patent:
52624170, Nov 16, 1993
Filed:
Jun 3, 1991
Appl. No.:
7/679069
Inventors:
Ronald B. Gammill - Portage MI
Sharon N. Bisaha - Lawton MI
Joseph M. Timko - Kalamazoo MI
Thomas M. Judge - Kalamazoo MI
Michael R. Barbachyn - Kalamazoo MI
Kyoung S. Kim - Lawrenceville NJ
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 31495
C07D40104
US Classification:
514254
Abstract:
A quinolone compound of Formula (I) ##STR1## as defined herein having antibacteria properties, pharmaceutical compositions containing the quinoline compound and method for treating bacterial infections in animals including humans.

4-Oxo- And 4H-Imidazo(5,1-C)(1,4)Benzoxazines Useful As Benzodiazepine Receptor-Binding Agents

View page
US Patent:
56101589, Mar 11, 1997
Filed:
Aug 3, 1994
Appl. No.:
8/285560
Inventors:
Sharon N. Bisaha - Titusville NJ
Ronald B. Gammill - Portage MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 31535
C07D49804
US Classification:
5142302
Abstract:
Imidazo-benzoxazines of Formula (I) and pharmaceutically acceptable salts thereof. ##STR1## where Q is selected from (A) through (H) ##STR2## or pharmaceutically acceptable salts thereof wherein the R groups are as defined herein. The imidazo-benzoxazines, Formula (I), of the present invention are useful as anxiolytics and sedatives.

Antibacterial Quinolone Compounds

View page
US Patent:
53859065, Jan 31, 1995
Filed:
Jul 20, 1993
Appl. No.:
8/094829
Inventors:
Ronald B. Gammill - Portage MI
Sharon N. Bisaha - Lawton MI
Joseph M. Timko - Kalamazoo MI
Thomas M. Judge - Kalamazoo MI
Michael R. Barbachyn - Kalamazoo MI
Kyoung S. Kim - Lawrenceville NJ
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 3147
C07D21556
US Classification:
514258
Abstract:
A quinolone compound of Formula (I) ##STR1## as defined herein having antibacteria properties, pharmaceutical compositions containing the quinoline compound and method for treating bacterial infections in animals including humans.
Control profile
Sharon N Bisaha from Lambertville, NJ, age ~77 Get Report